Ferreira, Isabella

Publications

Sort by

Co-Author Network

selected publications

Dynamic antigen expression and cytotoxic T cell resistance in HIV reservoir clones. Nature. 2026 Academic Article GET IT
Transcription of HIV-1 is heterogenous among authentic latent CD4+ T cell clones. The Journal of experimental medicine. 2025 Academic Article GET IT
Times cited: 1
Correction: Transcription of HIV-1 at sites of intact latent provirus integration. The Journal of experimental medicine. 2025 Article GET IT
Transcription of HIV-1 at sites of intact latent provirus integration. The Journal of experimental medicine. 2024 Academic Article GET IT
Times cited: 13
Hypoxia drives HIF2-dependent reversible macrophage cell cycle entry. Cell reports. 2024 Academic Article GET IT
Times cited: 5
Transcription of HIV-1 at sites of intact latent provirus integration. bioRxiv : the preprint server for biology. 2024 Article GET IT
Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly. Cell reports. 2023 Academic Article GET IT
Times cited: 15
SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa. Nature communications. 2022 Academic Article GET IT
Times cited: 24
Author Correction: SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2022 Article GET IT
Times cited: 4
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature. 2022 Article GET IT
Times cited: 1
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022 Academic Article GET IT
Times cited: 839
Aggregated Mycobacterium tuberculosis Enhances the Inflammatory Response. Frontiers in microbiology. 2021 Academic Article GET IT
Times cited: 207
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion. The Journal of infectious diseases. 2021 Academic Article GET IT
Times cited: 119
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature. 2021 Academic Article GET IT
Times cited: 1033
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature. 2021 Academic Article GET IT
Times cited: 560
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. Cell reports. 2021 Academic Article GET IT
Times cited: 319
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature. 2021 Academic Article GET IT
Times cited: 544
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies. medRxiv : the preprint server for health sciences. 2021 Article GET IT
SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021 Article GET IT
Times cited: 759
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation. medRxiv : the preprint server for health sciences. 2020 Article GET IT
Times cited: 762
Cell Cycle Regulation in Macrophages and Susceptibility to HIV-1. Viruses. 2020 Information Resource GET IT
Times cited: 19
Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death. eLife. 2018 Academic Article GET IT
Times cited: 8

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Harnessing Heterogeneity to Isolate and Eradicate the Clonal CD4 HIV Reservoir awarded by National Institute of Allergy & Infectious Diseases Principal Investigator 2025 - 2027

more ...

less ...

Background

education and training

Ph.D., University of Cambridge (United Kingdom) 2023
M.M.S., University of KwaZulu Natal (South Africa) 2019
B.S., University of KwaZulu Natal (South Africa) 2017
B.S., University of Cape Town (South Africa) 2015

Contact

full name

Isabella Ferreira

primary email

iaf4002@med.cornell.edu

VIVO Weill Cornell Medical College

Isabella Ferreira Postdoctoral Associate

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email